Filing Details

Accession Number:
0001193805-22-001729
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-15 16:06:28
Reporting Period:
2022-12-13
Accepted Time:
2022-12-15 16:06:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1280776 Immunic Inc. IMUX Pharmaceutical Preparations (2834) 562358443
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1773900 Joerg Neermann 1200 Avenue Of The Americas, Suite 200
New York NY 10036
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-13 35,000 $1.25 53,000 No 4 P Direct
Common Stock Acquisiton 2022-12-14 47,000 $1.26 100,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $1.23 to $1.28 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought by him at each separate price on December 13, 2022.
  2. The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $1.22 to $1.28 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought by him at each separate price on December 14, 2022.